Skip to content

MaxCyte MXCT Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Gross margin81.2%-0.5pp81.6%-6.9pp88.5%0.0pp88.5%-0.8pp
Operating margin-157.1%-24.6pp-132.5%-15.6pp-117%-55.2pp-61.8%-8.2pp
Net margin-135.1%-28.9pp-106.3%-14.4pp-91.8%-38.6pp-53.3%+3.0pp
Returns
Return on equity-23.6%-4.9pp-18.7%-3.1pp-15.6%-6.5pp-9.1%+3.8pp
Return on invested capital-28.4%-2.8pp-25.5%-4.7pp-20.8%-9.4pp-11.4%+3.6pp
Efficiency
Asset turnover0.1×0.0×0.2×0.0×0.1×0.0×0.2×0.0×
Liquidity
Current ratio8.3×-2.6×10.9×+0.2×10.7×-5.7×16.4×-1.0×
Leverage
Debt-to-equity0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×
Per Share
Book value per share$1.61-18.1%$1.97-12.5%$2.25-10.0%$2.50-13.9%
Valuation
Market capitalization$130.15M-46.8%$438.81M-10.0%$487.41M-12.6%$557.58M-46.0%
Price / sales-2.8×11.4×-0.4×11.8×-0.8×12.6×-17.9×
Price / book0.8×-0.5×2.1×0.0×2.1×-0.1×2.2×-1.7×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are MaxCyte's profit margins?
MaxCyte (MXCT) runs a 80.5% gross margin and a -141.8% operating margin, with a -121.2% net margin.
Where do MaxCyte's ratios come from?
Every ratio is computed from MaxCyte's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.